| 3K5V: reference: Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors., Zhang J, Adrian FJ, Jahnke W, Cowan-Jacob SW, Li AG, Iacob RE, Sim T, Powers J, Dierks C, Sun F, Guo GR, Ding Q, Okram B, Choi Y, Wojciechowski A, Deng X, Liu G, Fendrich G, Strauss A, Vajpai N, Grzesiek S, Tuntland T, Liu Y, Bursulaya B, Azam M, Manley PW, Engen JR, Daley GQ, Warmuth M, Gray NS, Nature. 2010 Jan 13. PMID: 20072125 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).